Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Interest Expenses (2020 - 2025)

Cytek Biosciences (CTKB) has disclosed Interest Expenses for 6 consecutive years, with -$725000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses rose 87.78% year-over-year to -$725000.0, compared with a TTM value of $474000.0 through Dec 2025, up 109.05%, and an annual FY2025 reading of $474000.0, up 109.05% over the prior year.
  • Interest Expenses was -$725000.0 for Q4 2025 at Cytek Biosciences, down from $494000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $687000.0 in Q4 2022 and bottomed at -$5.9 million in Q4 2024.
  • Average Interest Expenses over 5 years is $83450.0, with a median of $437000.0 recorded in 2021.
  • The sharpest move saw Interest Expenses surged 21950.0% in 2021, then plummeted 1605.84% in 2024.
  • Year by year, Interest Expenses stood at $541000.0 in 2021, then increased by 26.99% to $687000.0 in 2022, then plummeted by 42.65% to $394000.0 in 2023, then tumbled by 1605.84% to -$5.9 million in 2024, then skyrocketed by 87.78% to -$725000.0 in 2025.
  • Business Quant data shows Interest Expenses for CTKB at -$725000.0 in Q4 2025, $494000.0 in Q3 2025, and $414000.0 in Q2 2025.